Cogent Biosciences has 6 open roles at director level and above that TOPHEADS can see right now, most of them in Waltham, Massachusetts, United States. We have tracked its public job postings since June 2026.
One row per title. The description stays on their board. We do not host the application.
| Role | Where | Seen | Pay | |
|---|---|---|---|---|
| Senior Director, Global Market Access | Waltham, Massachusetts, United States | 30 Sept 2026first seen | $260K–305K · posted by the company | Open on their site |
| Director, Patient Advocacy & Engagement | Waltham, Massachusetts, United States | 24 Sept 2026first seen | $220K–250K · posted by the company | Open on their site |
| Director, National Payer Accounts | Waltham, Massachusetts, United States | 24 Sept 2026first seen | $240K–275K · posted by the company | Open on their site |
| Executive Director, Precision Medicine Executives | Waltham, Massachusetts, United States | 21 Sept 2026first seen | $290K–335K · posted by the company | Open on their site |
| Director, Corporate Counsel | Waltham, Massachusetts, United States | 14 Sept 2026first seen | $250K–290K · posted by the company | Open on their site |
| Director, Drug Substance Manufacturing & Development | Remote, United States | 27 Jul 2026first seen | $210K–240K · posted by the company | Open on their site |
Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases, particularly mastocytosis.
New director-and-above roles at this company against your brief, and a place to run the conversation. 14-day trial, no card.
Track Cogent Biosciences See roles that fit your briefThe same kind of seat, from the same public postings. Each company name is its own page.
| Company | Role | Where | Seen |
|---|---|---|---|
| 4D Molecular Therapeutics | Director, Corporate Counsel | Remote, United States | 27 Aug 2026 |
| Vaxcyte | Director, Global Drug Substance Commercialization, Conjugation | San Carlos, California, United States | 21 Sept 2026 |
| Ocular Therapeutix, Inc. | National Payer Accounts Director | Remote | 10 Sept 2026 |
| BridgeBio | Director, Patient Advocacy, International | Switzerland Office | 7 Sept 2026 |
| Revolution Medicines | Director, Senior Corporate Counsel, CNE | Basel, Switzerland | 24 Sept 2026 |
Nearby firms on the same public pages, by industry code. The line under each name is that firm's own industry.
Collected from public job postings on company career sites and job boards. "Director and above" is defined by job title. TOPHEADS is not affiliated with Cogent Biosciences.